Explainable AI in Clinical Decision Support: Building Trust and Meeting Regulatory Demands

In April 2019, the U.S. Food and Drug Administration (FDA) released its proposed regulatory framework for AI/ML-based Software as a Medical Device (SaMD), explicitly stating that transparency and explainability are prerequisites for market authorization and ongoing oversight of clinical decision support systems (CDSS) powered by artificial intelligence[2]. This marked a turning point: explainable AI (XAI) is no longer a theoretical ideal but a concrete requirement for health systems seeking to deploy AI-driven tools in patient care. As regulatory expectations tighten and clinicians demand greater clarity from algorithmic recommendations, explainability has become the linchpin for trustworthy AI systems in healthcare.

The Trust Gap: Why Explainability Matters in Clinical Decision Support

Clinicians are trained to demand evidence, reason through uncertainty, and justify their decisions—habits that are fundamentally at odds with the “black box” nature of many high-performing AI models. When a CDSS recommends a diagnostic path or treatment protocol, the absence of a transparent rationale undermines clinician confidence and can stall adoption, regardless of the model’s statistical accuracy. A systematic review published in the Journal of Biomedical Informatics found that lack of explainability was a primary barrier to the integration of AI in clinical workflows, with clinicians expressing reluctance to act on opaque recommendations that could not be interrogated or justified to patients and peers[1]. This skepticism is not merely academic; it reflects a practical concern for patient safety, professional accountability, and the ethical imperative to “do no harm.”

Explainable AI addresses this trust gap by making the reasoning behind AI outputs accessible and interpretable to human users. Techniques such as feature importance rankings, counterfactual explanations, and visualizations of decision pathways allow clinicians to understand which variables influenced a recommendation and to assess whether the AI’s logic aligns with established clinical knowledge. This transparency enables clinicians to validate AI outputs, identify potential errors or biases, and integrate algorithmic insights into their own expert judgment. As a result, XAI not only fosters trust but also supports shared decision-making, where human and machine intelligence are mutually reinforcing rather than adversarial.

The stakes are particularly high in high-risk domains such as oncology, cardiology, and critical care, where erroneous recommendations can have life-or-death consequences. In these contexts, explainability is not a luxury but a necessity: it provides the audit trail required for post-hoc analysis of adverse events, facilitates regulatory reporting, and underpins the continuous improvement of AI models through clinician feedback. Without explainability, health systems risk both operational inefficiency and regulatory noncompliance, exposing themselves to legal liability and reputational damage.

Regulatory Momentum: From Guidance to Mandate

The regulatory landscape for AI in healthcare is evolving rapidly, with explainability emerging as a central tenet of both pre-market review and post-market surveillance. The FDA’s 2019 discussion paper on AI/ML-based SaMD set out clear expectations: manufacturers must provide “information that is essential to the user’s understanding of the device’s logic and outputs,” including the ability to “review the basis for a recommendation” and “identify and mitigate potential risks”[2]. This guidance has since been echoed by international bodies such as the European Medicines Agency (EMA) and the International Medical Device Regulators Forum (IMDRF), which have called for transparency, traceability, and human oversight in AI-enabled medical devices.

These regulatory trends are not limited to the device approval process. The FDA’s “Predetermined Change Control Plan” for adaptive AI models requires manufacturers to specify how changes to algorithms will be documented, validated, and communicated to users—an implicit demand for ongoing explainability as models evolve in real-world settings. Similarly, the European Union’s Artificial Intelligence Act, currently under negotiation, proposes risk-based requirements for explainability, documentation, and human-in-the-loop controls for high-risk AI systems, including those used in healthcare.

Regulators are increasingly aware that explainability is not just a technical feature but a safeguard for patient safety, ethical practice, and public trust. As noted in Nature Medicine’s review of trustworthy AI in healthcare, “explainability is essential for accountability, enabling clinicians and regulators to understand, challenge, and improve AI-driven decisions”[3]. The direction of travel is clear: health systems and vendors that cannot demonstrate explainable, auditable AI will face mounting barriers to market entry, reimbursement, and clinical acceptance.

Balancing Accuracy and Interpretability: The Technical Frontier

Despite the regulatory and ethical imperatives, achieving explainability in clinical AI is technically challenging, particularly for complex models such as deep neural networks that excel at pattern recognition but defy intuitive understanding. The trade-off between accuracy and interpretability is a persistent dilemma: simpler models (e.g., decision trees, logistic regression) are inherently more transparent but may underperform on large, heterogeneous clinical datasets, while more sophisticated architectures (e.g., convolutional neural networks, transformers) deliver superior predictive power at the cost of opacity.

Recent advances in XAI research are beginning to bridge this gap. Post-hoc explanation methods—such as SHAP (SHapley Additive exPlanations), LIME (Local Interpretable Model-agnostic Explanations), and attention visualization—allow developers to extract human-understandable rationales from otherwise inscrutable models. These techniques can highlight which clinical features (e.g., lab values, imaging findings, patient demographics) most strongly influenced a recommendation, enabling clinicians to cross-check AI outputs against their own knowledge and experience. Importantly, these explanations can be tailored to different user groups: a radiologist may require a pixel-level heatmap of an abnormality, while a hospital administrator may prefer a high-level summary of risk factors.

However, not all explanations are equally useful or trustworthy. The field is grappling with the challenge of “explanation veracity”—ensuring that the explanations provided are faithful to the model’s actual reasoning, rather than plausible-sounding rationalizations. There is also the risk of information overload: too much detail can obscure rather than clarify, while oversimplification can mask critical nuances. Effective XAI in clinical decision support must therefore strike a balance between completeness, clarity, and clinical relevance, delivering actionable insights without sacrificing rigor or transparency.

Ongoing research is also exploring hybrid approaches that combine interpretable models with high-performing black-box components, leveraging ensemble methods, rule extraction, and human-in-the-loop feedback to optimize both accuracy and explainability. The ultimate goal is to create AI systems that are not only technically robust but also epistemically transparent—enabling clinicians to understand, trust, and improve upon algorithmic recommendations in the context of real-world patient care[1].

Operational Implications: What CTOs and CISOs Must Do Now

For CTOs and CISOs at health systems, the operational mandate is clear: explainability must be embedded into the procurement, deployment, and governance of all AI-enabled clinical decision support systems. This is not a one-off compliance exercise but an ongoing commitment to transparency, accountability, and continuous improvement.

First, technology leaders should audit their current and planned AI deployments for explainability, mapping each system’s capacity to generate user-facing rationales, support post-hoc analysis, and document decision pathways. This includes evaluating vendor claims about XAI features, demanding evidence of regulatory alignment, and involving clinicians in usability testing to ensure that explanations are meaningful and actionable at the point of care.

Second, organizations must establish governance frameworks that operationalize explainability across the AI lifecycle. This includes defining standards for documentation, version control, and change management; implementing audit trails for all AI-driven recommendations; and integrating explainability metrics into model validation and monitoring processes. CISOs should pay particular attention to the security and integrity of explanation data, ensuring that sensitive patient information is protected and that explanation mechanisms cannot be manipulated or spoofed.

Third, CTOs should invest in clinician education and engagement, providing training on how to interpret and interrogate AI outputs, recognize potential biases, and escalate concerns when explanations are inadequate or inconsistent with clinical judgment. This human-in-the-loop approach not only enhances trust but also creates a feedback loop for model refinement and risk mitigation.

Finally, health systems must stay abreast of evolving regulatory requirements, proactively engaging with the FDA, EMA, and other authorities to anticipate new expectations for explainability, transparency, and human oversight. This may involve participating in regulatory sandboxes, contributing to standards development, and collaborating with peer institutions to share best practices and lessons learned.

The bottom line: explainable AI is now table stakes for clinical decision support. Health systems that invest in transparent, interpretable, and trustworthy AI infrastructure will not only meet regulatory demands but also earn the confidence of clinicians, patients, and the public—laying the foundation for safe, effective, and ethical AI-driven care.